Tag: MXC

MGC Pharmaceuticals ASX MXC RMIT botanical cancer cannabis cultivation research

MGC Pharmaceuticals receives cannabis research and import permit grants in Australia

MGC Pharmaceuticals (ASX: MXC) has reached yet another regulatory milestone after the biopharmaceutical company confirmed it has been granted a cannabis research cultivation permit by the Australian O...
MGC Pharmaceuticals ASX MXC Mahatma Gandhi Mission’s Medical College & Hospital Aurangabad India World Health Organisation WHO

MGC Pharma expands ArtemiC Phase II trial to include COVID-19 patients in India

MGC Pharmaceuticals (ASX: MXC) has confirmed the footprint of a Phase II trial into the efficacy of its ArtemiC anti-inflammatory medicated spray on the COVID-19 virus will be expanded to include the ...
MGC Pharma Micelle Technology clinical trial anti-infective drug COVID-19 patients ASX MXC

MGC Pharma and Micelle Technology to begin clinical trial using anti-infective drug on COVID-19 patients

MGC Pharmaceuticals (ASX: MXC) is about to kick-off a phase II clinical trial evaluating a natural anti-infective drug on COVID-19 patients. Israel’s Nazareth Hospital Human Research Ethics Committ...
MGC Pharmaceuticals ASX MXC cannabinoids brain cancer research cannabis

MGC Pharmaceuticals presents ‘ground-breaking’ research into effect of cannabis on brain cancer

Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) has completed what it calls “ground-breaking research” that highlights the effectiveness of cannabinoids on various brain cancers. Earlier t...
MGC Pharma ASX MXC CannEpil UK epilepsy distribution

MGC Pharma officially enters UK with CannEpil distribution to begin immediately

Medicinal cannabis producer MGC Pharmaceuticals’ (ASX: MXC) first CannEpil shipment to the UK has landed on British soil and will be immediately distributed to the country’s pharmacies and patients. ...
MGC Pharmaceuticals ASX MXC nutraceuticals CBD Chinese health products YuShop Global

MGC Pharmaceuticals enters Chinese market with CBD products

Biopharmaceutical company MGC Pharmaceuticals (ASX: MXC) is entering the Chinese health market, inking a deal with e-commerce import platform YuShop Global to sell its range of cannabis-based nutraceu...
MGC Pharmaceuticals ASX MXC TGA approval CannEpil medicinal cannabis product Australia

MGC Pharmaceuticals receives TGA approval to market its CannEpil medicinal cannabis product in Australia

Aspiring bio-pharmaceutical company MGC Pharmaceuticals (ASX: MXC) has received formal authorisation to supply its CannEpil product through specialist prescribers under the ‘Authorised Prescriber Sche...
MGC Pharmaceuticals ASX MXC cannabis potential treatment fight against dementia

MGC Pharmaceuticals positions cannabis as a potential treatment in the fight against dementia

Biopharma developer MGC Pharmaceuticals (ASX: MXC) plans to apply the potential benefits of cannabis to mitigate the impact of dementia. Earlier this morning, the company announced it has been gran...
Harvey Nichols UK MGC Pharmaceuticals ASX MXC CBD Derma range cannabidiol

UK’s Harvey Nichols to expand MGC Pharmaceuticals CBD Derma range

MGC Pharmaceuticals (ASX: MXC) has received strong commercial news this morning with the news that UK-based retailer Harvey Nichols has decided to expand the sale of MGC’s premium cannabidiol (CBD) ‘D...
MGC Pharmaceuticals ASX MXC GMP certificate manufacturing licence CannEpil

MGC Pharmaceuticals receives key medical cannabis certification and manufacturing licence

Biopharma company MGC Pharmaceuticals (ASX: MXC) has received its GMP certification and formal manufacturing licence to produce Good Manufacturing Practice (GMP) grade medical cannabis medicines conta...
Malta medical cannabis legislation ASX MGC Pharmaceuticals MXC

MGC Pharmaceuticals celebrates medical cannabis legislative change in Malta

The final piece of its cannabis production line has now slotted into place for MGC Pharmaceuticals (ASX: MXC) after final legislation was passed by the Maltese Parliament last week. The legislation...
MGC Pharmaceutics ASX MGC CBD Herbal Replenish cream launched

MGC Pharmaceuticals launches latest cannabidiol skincare product

Medicinal cannabis and its expansive set of applications continue to encroach upon commercial markets with MGC Pharmaceuticals (ASX: MXC) launching yet another cannabidiol-based product into world mar...
MGC Pharma ASX MXC medical cannabis facility Malta

MGC Pharma gets go-ahead to build medical cannabis facility in Malta, tops up cash

MGC Pharma (ASX: MXC) has grown its medical cannabis production capabilities after the Maltese Government gave the company the go-ahead to construct and operate a medical cannabis facility in Malta. ...
MGC Pharmaceuticals ASX MXC CannEpil production

MGC Pharmaceuticals commences production of CannEpil product for epilepsy

Medicinal cannabis is emerging into mainstream consumption, one approval at a time for MGC Pharmaceuticals (ASX: MXC). As one of the world’s most avant-garde market niches, medicinal cannabis produ...
MGC Derma Pharma ASX MXC Cult Beauty

MGC Pharma’s cannabidiol cosmetics launch on Cult Beauty online store

Australian medicinal cannabis company MGC Pharmaceuticals (ASX: MXC) has officially launched its range of MGC Derma and Derma Plus cannabidiol (CBD) cosmetic and skin care products on the global onlin...
MGC Pharmaceuticals ASX MXC CannEpil medicinal cannabis Europe Good Manufacturing Practice

MGC Pharma granted green light to start manufacturing CannEpil for distribution

MGC Pharmaceuticals (ASX: MXC) has been given the greenlight to begin manufacturing its medicinal cannabis-based products at its European production facility, after receiving interim Good Manufacturin...
MGC Pharma ASX MXC Cult Beauty cannabis cosmetics distribution

MGC Pharma gains cosmetics distribution boost via Cult Beauty

MGC Pharmaceuticals (ASX: MXC), an Australian medicinal cannabis company, has announced that its European subsidiary MGC Derma has signed a sales and distribution agreement with Cult Beauty, a leading...
MGC Pharmaceuticals ASX MXC cannabis Derma Plus cream psoriasis

MGC Pharma’s cannabis-based herbal cream now available for psoriasis sufferers

MGC Pharmaceuticals (ASX: MXC) has officially launched its cannabidiol-based Derma Plus herbal cream for psoriasis sufferers throughout Australasia, the European Union and US. Patients in these reg...
MGC Pharma ASX MXC cannabis CBD-based psoriasis cream derma plus

MGC Pharma to launch CBD-based psoriasis cream next month

Psoriasis suffers will have a new treatment available from January 1st next year after MGC Pharmaceuticals (ASX: MXC) scheduled the launch for its cannabidiol-based Derma Plus product line. Created...
MGC Pharmaceuticals ASX MXC CBD extract supply Mabsut Life

MGC Pharmaceuticals secures CBD extract supply agreement worth $1m

MGC Pharmaceuticals (ASX: MXC) has secured yet another supply agreement, this time with European distributor Mabsut Life, with this contract, alone, expected to generate more than A$1 million in annua...
MGC Pharmaceutical MXC ASX Australian market epilepsy drug CannEpil

MGC Pharma breaks into Australian pharmaceutical market with epilepsy drug

MGC Pharmaceuticals (ASX: MXC) has inked a heads of agreement with Australian distributor HL Pharma Pty Ltd to distribute its CannEpil product to Australian epilepsy patients from early 2018. This ...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS